Article: Citicoline vs choline: what's actually different

Citicoline vs choline: what's actually different

Choline, citicoline, and citicolineare related but distinct compounds arranged in a biochemical hierarchy. Choline is the simplest: a basic nutrient found in food. Citicoline (also called CDP-choline) is a more complex molecule that the body produces from choline and that serves as a direct precursor to both phosphatidylcholine and acetylcholine. citicolineis a branded, standardised form of citicoline manufactured by Kyowa Hakko. It is the form used in the majority of published human cognitive research — including studies measuring frontal lobe bioenergetics at 500 mg.

What choline, citicoline, and citicolineactually are

These three names describe three different points on a molecular pathway, and the differences between them matter significantly for both absorption and research validity.

Choline is a water-soluble nutrient classified in the B vitamin family. It is found naturally in eggs, liver, and meat. In the body, choline is used to synthesise phosphatidylcholine — a major structural component of all cell membranes — and acetylcholine, the neurotransmitter involved in attention, memory, and muscle control. Choline is an essential nutrient; the human body cannot produce sufficient amounts on its own and requires dietary intake.

Citicoline (cytidine-5'-diphosphocholine, or CDP-choline) is a naturally occurring compound found in every cell in the body. It is an intermediate in the biosynthetic pathway for phosphatidylcholine, sitting between choline and the finished structural phospholipid. When you take citicoline as a supplement, the compound crosses the blood-brain barrier more effectively than choline alone and is broken down into two components: cytidine (which converts to uridine in the brain, a nucleotide that supports membrane synthesis) and choline (which is then available for acetylcholine and phosphatidylcholine production). This dual-pathway action is what distinguishes citicoline from simpler choline sources.

citicoline is a proprietary, standardised form of citicoline manufactured by Kyowa Hakko, a Japanese biotechnology company. It is produced through fermentation rather than chemical synthesis, which results in a consistent purity and concentration profile. citicolineis the form of citicoline used in the large majority of published clinical trials on citicoline's cognitive effects in humans. When a study claims to have tested citicoline at 500 mg and measured cognitive outcomes, that study almost always used citicolinespecifically — not a generic citicoline compound.

Compound Type Key action Blood-brain barrier?
Choline Essential nutrient Precursor to phosphatidylcholine & acetylcholine Limited crossing at physiological doses
Citicoline (CDP-choline) Naturally occurring intermediate Precursor to phosphatidylcholine; dual cytidine + choline pathway Crosses effectively
citicoline Standardised branded citicoline Identical biochemical action to citicoline; consistent purity via fermentation Crosses effectively; same as citicoline

What the research shows

Frontal lobe bioenergetics — 6 weeks at 500 mg

The most cited citicolinestudy in the context of cognitive performance is from Silveri, Dikan, Ross, Jensen, Kamiya, Kawada, Renshaw and Yurgelun-Todd (2008), conducted at McLean Hospital and Harvard Medical School. Sixteen healthy adults with a mean age of 47.3 years received either 500 mg or 2,000 mg citicoline (CDP-choline) daily for six weeks. Researchers used phosphorus-31 magnetic resonance spectroscopy (a non-invasive neuroimaging technique) to measure high-energy phosphate metabolites in the frontal lobe (anterior cingulate cortex) and a comparison region (parieto-occipital cortex).

After six weeks, those receiving the 500 mg dose showed statistically significant changes in the anterior cingulate cortex: phosphocreatine levels increased by 7%, beta-nucleoside triphosphates (predominantly ATP in brain tissue) increased by 14%, and the ratio of phosphocreatine to inorganic phosphate increased by 32%. These changes were regionally specific — they occurred in the frontal lobe but not in the comparison region, which suggests a targeted effect rather than a systemic one. Importantly, effects were of greater magnitude at 500 mg than at 2,000 mg, indicating a non-linear dose-response relationship. PubMed 18816480

Memory in older adults — 12 weeks at 500 mg

Nakazaki, Mah, Sanoshy, Citrolo and Watanabe (2021) conducted a randomised, double-blind, placebo-controlled trial in 100 healthy adults aged 50–85 with age-associated memory impairment. Participants received citicolineat 500 mg per day or placebo for 12 weeks. Memory was assessed using the Cambridge Brain Sciences computerised battery. Those receiving citicolineshowed significantly greater improvement in episodic memory (Paired Associate test: mean change 0.15 vs 0.06, p=0.0025) and composite memory scores (mean 3.78 vs 0.72, p=0.0052) at the 12-week endpoint. This study is notable for its focus on healthy older adults rather than a clinical patient population, making the findings more directly relevant to ageing women without diagnosed conditions. PubMed 33978188

Vigilance and working memory — 2 weeks at 500 mg

A shorter placebo-controlled trial (published in Basic and Clinical Neuroscience, 2020) enrolled 40 healthy volunteers in two groups: 20 received 500 mg citicoline daily for two weeks, and 20 received placebo. Citicoline significantly improved measures of psychomotor performance, human vigilance, and working memory compared to baseline and to the placebo group (p<0.01 across vigilance parameters). Oxidative stress markers (serum MDA levels) also decreased significantly in the citicoline group versus a significant increase in the placebo group, which the researchers linked to citicoline's neuroprotective and antioxidant properties. This study demonstrates that some effects are detectable within a shorter window at this dose.

Why the dose is 500 mg — not more and not less

The dose-response finding from Silveri et al. (2008) is counterintuitive and worth examining closely. The 500 mg dose produced greater increases in frontal lobe high-energy phosphates than the 2,000 mg dose. One proposed explanation is that lower doses allow the body to integrate citicoline more precisely into existing membrane pathways, whereas higher doses may saturate or exceed the uptake and utilisation capacity of the target tissue.

This means that 500 mg is not a conservative choice or a cost-cutting measure — it is specifically the dose at which the research found the greatest effect on frontal lobe bioenergetics. Using 250 mg would take the product outside the studied range. Using 1,000 mg or more would not improve on the research outcome and might reduce it.

A meaningful portion of cognitive supplements on the UK market use citicoline at doses well below 500 mg — sometimes as low as 50 mg — because it allows a brand to list the ingredient on the label without matching the research dose. At 50 mg, there is no published human RCT demonstrating the same frontal lobe effects found at 500 mg.

How citicolineis used in The Foundation

The Foundation contains citicolineat 500 mg per daily serving — the dose used in both the Silveri et al. (2008) bioenergetics study and the Nakazaki et al. (2021) memory trial. No more, no less. The choice of citicolinespecifically, rather than a generic citicoline source, means the ingredient matches the manufacturing standard used in the published research. This matters because the consistency of the compound's purity and concentration is part of what the trial tested.

Frequently asked questions

Can I get enough citicoline from food instead of a supplement?

The precursor compound choline is found in food — eggs, liver, and meat are the richest sources. However, converting dietary choline into citicoline and then into phosphatidylcholine in sufficient quantities for the neurological effects studied at 500 mg supplemental doses is not straightforward to achieve through diet alone. The published research used supplemental citicolineat a controlled dose; there is no dietary equivalent that has been tested in the same way.

Is citicolinejust a more expensive version of regular citicoline?

citicolineis a standardised, fermentation-derived form of citicoline with a consistent purity profile. The research base for cognitive effects in humans — including frontal lobe bioenergetics at 500 mg — was conducted using citicoline. While generic citicoline products exist, their manufacturing standards and purity profiles vary between suppliers. When a supplement company cites the Silveri et al. (2008) or Nakazaki et al. (2021) trials to justify their citicoline ingredient, their product should use citicolineto accurately claim it matches those studies.

What does "frontal lobe bioenergetics" mean in plain English?

The frontal lobe handles much of what we call "higher cognitive function" — planning, sustained attention, working memory, and processing speed. Brain cells use ATP (adenosine triphosphate) as their primary energy currency. Measuring frontal lobe bioenergetics using MRS gives researchers a direct view of how much energy the region is generating and storing. The Silveri et al. (2008) finding that 500 mg citicolineincreased ATP and phosphocreatine in the anterior cingulate cortex indicates a measurable increase in the region's energy availability — not just a subjective impression.

Why did the 2,000 mg dose perform worse than 500 mg in the bioenergetics trial?

This is not fully explained in the literature. One hypothesis is that cellular uptake and phospholipid synthesis pathways have a saturation point — beyond which additional substrate does not increase product output. Another possibility is a dose-dependent feedback mechanism. What the study confirms is that more is not always better with citicoline, and that 500 mg represents the dose at which the greatest bioenergetics effect was observed. This is why the research dose is 500 mg and why matching it specifically matters more than exceeding it.

How is citicoline different from lecithin or phosphatidylcholine supplements?

Lecithin is a mixture of phospholipids (including phosphatidylcholine) extracted from soy or sunflowers. Phosphatidylcholine is the finished membrane phospholipid that citicoline helps synthesise. Citicoline sits upstream in the pathway — it is a building-block precursor, not the finished structure. Taking finished phosphatidylcholine bypasses the synthesis steps that citicoline initiates, which means the two have different effects on neurological metabolism. Citicoline also provides the cytidine pathway (for uridine and further membrane synthesis) that phosphatidylcholine supplementation does not.

Further reading

References

  1. Silveri MM, Dikan J, Ross AJ, Jensen JE, Kamiya T, Kawada Y, Renshaw PF, Yurgelun-Todd DA. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy. NMR Biomed. 2008;21(10):1066–75. PubMed 18816480
  2. Nakazaki E, Mah E, Sanoshy K, Citrolo D, Watanabe F. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Nutr. 2021;151(8):2153–2160. PubMed 33978188
  3. Naghizadeh S, Mahboudi M, Salimi M, Yazdanpanah S, Sadeghi A, Karimzadeh F. Citicoline Improves Human Vigilance and Visual Working Memory: The Role of Neuronal Activation and Oxidative Stress. Basic Clin Neurosci. 2020;11(4):491–498. PMCID PMC7878037

Food supplements are not a substitute for a varied, balanced diet and a healthy lifestyle. Do not exceed the recommended daily dose. Always speak to your GP if you are taking medication or have a medical condition.

Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Read more

French maritime pine bark research: what 30 years of studies actually show

French maritime pine bark extract — French Maritime Pine Bark Extract — has been the subject of peer-reviewed research for more than three decades. A look at what the major studies in perimenopausa...

Read more

Why 28 mg standardised saffron extract: the crocin and safranal question

The dose of saffron that has been studied in perimenopausal women is 28 mg of saffron extract per day. 22 mg did not reach significance in the same trial framework. Here is why standardisation matt...

Read more